EXHIBIT 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, par value $0.001 per share, of Achieve Life Sciences, Inc. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G.
Date: December 29, 2021
| SVB Financial Group | ||
| By | /s/ Karen Hon | |
| Name: | Karen Hon | |
| Title: | Chief Accounting Officer | |
| SVB Innovation Credit Fund VIII, L.P. | ||
| By: SVB Innovation Credit Partners VIII, LLC, its general partner | ||
| By | /s/ Andrew Olson | |
| Name: | Andrew Olson | |
| Title: | Chief Financial Officer | |
| SVB Innovation Credit Partners VIII, LLC | ||
| By | /s/ Andrew Olson | |
| Name: | Andrew Olson | |
| Title: | Chief Financial Officer | |
[Signatures continue on next page]
| Innovation Credit Fund VIII-A, L.P. | ||
| By: SVB Innovation Credit Partners VIII-A, LLC, its general partner | ||
| By | /s/ Andrew Olson | |
| Name: | Andrew Olson | |
| Title: | Chief Financial Officer | |
| SVB Innovation Credit Partners VIII-A, LLC | ||
| By | /s/ Andrew Olson | |
| Name: | Andrew Olson | |
| Title: | Chief Financial Officer | |